AllNewsPhotosVideos

Sanjeev Krishan

Sanjeev krishan, Latest News

Glenmark Pharmaceuticals receives ANDA approval for Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials - Hindi News | Glenmark Pharmaceuticals receives ANDA approval for Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials | Latest business News at Lokmatnews.in

Business :Glenmark Pharmaceuticals receives ANDA approval for Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials

Glenmark Pharmaceuticals Ltd (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials, the generic version of BROVANA®1 Inhalation So ...

Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg - Hindi News | Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg | Latest business News at Lokmatnews.in

Business :Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg

Glenmark Pharmaceuticals Limited (Glenmark) has launched Rufinamide Tablets USP, 200 mg and 400 mg, a therapeutic equivalent of Banzel® Tablets, 200 mg and 400 mg of Eisai, Inc. ...

Glenmark and Bausch Health join hands to commercialise RYALTRIS nasal spray in Canada - Hindi News | Glenmark and Bausch Health join hands to commercialise RYALTRIS nasal spray in Canada | Latest business News at Lokmatnews.in

Business :Glenmark and Bausch Health join hands to commercialise RYALTRIS nasal spray in Canada

Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced that its subsidiary Glenmark Specialty S.A. in Switzerland and an affiliate of Bausch Health Companies Inc. have entered into an exclusive licensing a ...